Drug Profile
Calcipotriol - MC2 Therapeutics
Alternative Names: Calcipotriene MC2-16 PAD™ Cream; MC2-01 (calcipotriol); MC2-04; MC2-16; PADcalciLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Drug Delivery Solutions ApS
- Developer Drug Delivery Solutions ApS; MC2 Therapeutics
- Class Antipsoriatics; Cyclohexanes; Cyclopropanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Plaque psoriasis
- Discontinued Psoriasis
Most Recent Events
- 28 May 2021 No recent reports of development identified for preclinical development in Plaque-psoriasis in Denmark (Topical, Cream)
- 18 Mar 2021 Chemical structure information added
- 03 Apr 2017 Discontinued - Phase-II for Plaque psoriasis of MC2-01 calcipotriol in Germany (Topical, Ointment), because not listed on MC2 Therapeutics pipeline, April 2017